The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine Rouphael, Wendy Nesheim, Michele Paine et al.|The Lancet|2017Cited by 423
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E. Tomalin et al.|Nature Immunology|2022Cited by 141
Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccinationSlim Fourati, Rafick‐Pierre Sékaly, Ofer Levy et al.|Nature Immunology|2022Cited by 138
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a studyLindsey R. Baden, Hong‐Van Tieu, Daniel J Stieh et al.|The Lancet HIV|2020Cited by 91
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal studyMonica Kraft, Nadine Rouphael, Holden T. Maecker et al.|Science Immunology|2021Cited by 74